Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.953483056155839e-27,inf,inf,"['RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS5', 'RPSA', 'RPS3A', 'RPL24', 'RPL26', 'RPL29', 'UBA52', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS23']",1.0753473912743883e-24,0,0,55
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,9.236200589798808e-20,inf,inf,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UQCRFS1', 'ATP5MF', 'COX8A', 'ATP5PF', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6']",1.256123280212638e-17,0,0,40
3,Nonalcoholic fatty liver disease WP4396,4.3763417323339506e-13,17.87162162162162,508.5797610069632,"['NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'SOCS3', 'UQCRFS1', 'COX8A', 'XBP1', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS']",3.9678831706494486e-11,0,0,35
4,Mitochondrial CIV Assembly WP4922,1.037854936821487e-08,inf,inf,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",7.057413570386112e-07,0,0,17
5,Oxidative phosphorylation WP623,1.5910402130350003e-08,37.750936329588015,677.8668631728974,"['ATP5PF', 'NDUFB7', 'NDUFA6', 'NDUFA11', 'NDUFB10', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFB2', 'NDUFC2', 'ATP5MC3', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'ATP5MF']",8.655258758910402e-07,0,0,19
6,Mitochondrial complex I assembly model OXPHOS system WP4324,2.8084216336206224e-06,27.558441558441558,352.27646992979413,"['NDUFA13', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF3']",0.00012731511405746822,0,0,14
7,Mitochondrial complex III assembly WP4921,0.0005382128601929445,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.0209134139960687,0,0,7
8,Pyrimidine metabolism WP4022,0.0011489382971651536,15.574311926605505,105.42122449687763,"['POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.03906390210361522,0,0,8
9,Cori Cycle WP1946,0.0015831640192347902,inf,inf,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.047846734803540326,0,0,6
10,Alzheimer's disease WP2059,0.0020020484603155493,6.500920810313075,40.3940200833863,"['PSENEN', 'ATP5MD', 'CDK5', 'BAD', 'LPL', 'CYCS', 'CALM3', 'CALM1', 'GAPDH', 'CALM2']",0.05445571812058294,0,0,10
11,Ciliary landscape WP4352,0.0022169480795218967,5.368081180811808,32.80769253251896,"['PSMD8', 'EXOSC4', 'ARHGDIA', 'NEFL', 'COPS7A', 'DYNLRB1', 'CALM1', 'DYNLL1', 'COX6C', 'CALM2', 'LSM4']",0.054819079784541445,0,0,11
12,7q11.23 copy number variation syndrome WP4932,0.0040213539097062115,7.779816513761468,42.91453092087916,"['ATP5F1B', 'CFL1', 'HMGA1', 'ATP5MC3', 'GAPDH', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.09115068862000747,0,0,8
13,Glycolysis and Gluconeogenesis WP534,0.004873972080646005,4.871086556169429,25.932914931098242,"['LDHA', 'TPI1', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'ALDOC', 'ENO2', 'ALDOA', 'GAPDH']",0.10197849276428565,0,0,10
14,Computational Model of Aerobic Glycolysis WP4629,0.007852904559133464,11.638025594149909,56.40801815412439,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH']",0.1525707171488787,0,0,6
15,Eukaryotic Transcription Initiation WP405,0.013648949187285696,inf,inf,"['TAF13', 'POLR2I', 'POLR3K', 'POLR2K']",0.24750094526278063,0,0,4
16,G13 Signaling Pathway WP524,0.01999200412599303,9.680656934306569,37.87482367418256,"['CFL2', 'CFL1', 'ARHGDIG', 'CALM1', 'CALM2']",0.30210139568167244,0,0,5
17,Glycolysis in senescence WP5049,0.01999200412599303,9.680656934306569,37.87482367418256,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'GAPDH']",0.30210139568167244,0,0,5
18,NO/cGMP/PKG mediated Neuroprotection WP4008,0.01999200412599303,9.680656934306569,37.87482367418256,"['BAD', 'NEFL', 'CYCS', 'CALM1', 'CALM2']",0.30210139568167244,0,0,5
19,Cell cycle WP179,0.02182598784556183,3.8825688073394495,14.84948199379133,"['CDKN2D', 'PTTG1', 'GADD45B', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.31245624705225356,0,0,8
20,VEGFA-VEGFR2 Signaling Pathway WP3888,0.03252877365652206,1.7071630074819084,5.848109219717294,"['SET', 'CRIP2', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'TMSB4X', 'CFL1', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ATP6V1E1', 'CCT7', 'TMSB10', 'SDF2L1', 'SSR4', 'DNAJA1', 'CYCS', 'RPL26', 'CALR', 'ALDOA', 'GAPDH', 'SLC25A11', 'EIF4G2', 'ARF6']",0.44239132172870005,0,0,27
21,Adipogenesis WP236,0.036001386985873546,2.911764705882353,9.679281869835243,"['SOCS3', 'CYP26B1', 'GADD45B', 'GADD45A', 'DDIT3', 'HMGA1', 'LPL', 'NDN', 'MIF']",0.4534744722364151,0,0,9
22,HIF1A and PPARG regulation of glycolysis WP2456,0.04000398335551399,inf,inf,"['LDHA', 'TPI1', 'GAPDH']",0.4534744722364151,0,0,3
23,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.04000398335551399,inf,inf,"['MDH2', 'SCO2', 'HMGA1']",0.4534744722364151,0,0,3
24,Pathways in clear cell renal cell carcinoma WP4018,0.04001245343262486,3.103119266055046,9.987589625381126,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOC', 'ENO2', 'ALDOA', 'GAPDH']",0.4534744722364151,0,0,8
25,Metabolic reprogramming in colon cancer WP4290,0.04780103546305924,3.8720292504570386,11.773710230251114,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'GAPDH']",0.5117559784902482,0,0,6
26,Synaptic Vesicle Pathway WP2267,0.04963964056567106,7.730418943533698,23.214181847879562,"['RAB3A', 'AP2S1', 'SLC25A4', 'AP2M1']",0.5117559784902482,0,0,4
27,Selenium Micronutrient Network WP15,0.05079930668837023,2.4263351749539597,7.23016963919169,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.5117559784902482,0,0,10
28,Myometrial relaxation and contraction pathways WP289,0.07980541057243476,1.9408502772643252,4.906787752169094,"['RGS4', 'CREB3', 'GNG3', 'PRKAR1A', 'YWHAB', 'CRH', 'CALM3', 'IGFBP6', 'CALM1', 'CALM2', 'ACTG1', 'YWHAH']",0.775252559846509,0,0,12
29,Melanoma WP4685,0.08558798667375615,2.9012797074954295,7.13195580021914,"['GADD45B', 'BAD', 'GADD45A', 'CALM3', 'CALM1', 'CALM2']",0.8027562888021266,0,0,6
30,DNA Repair Pathways Full Network WP4946,0.108934961591079,3.8615664845173043,8.561109336753939,"['FEN1', 'CENPX', 'CETN2', 'POLE3']",0.8096701650765828,0,0,4
31,Photodynamic therapy-induced unfolded protein response WP3613,0.108934961591079,3.8615664845173043,8.561109336753939,"['XBP1', 'DDIT3', 'DNAJB9', 'CALR']",0.8096701650765828,0,0,4
32,Airway smooth muscle cell contraction WP4962,0.1171081713346053,inf,inf,"['CALM1', 'CALM2']",0.8096701650765828,0,0,2
33,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.1171081713346053,inf,inf,"['COX8A', 'GSTP1']",0.8096701650765828,0,0,2
34,Base Excision Repair WP4752,0.1171081713346053,inf,inf,"['FEN1', 'POLE3']",0.8096701650765828,0,0,2
35,Fatty acid beta-oxidation WP143,0.1171081713346053,inf,inf,"['TPI1', 'LPL']",0.8096701650765828,0,0,2
36,mRNA Processing WP411,0.1171081713346053,inf,inf,"['SF3B5', 'SNU13']",0.8096701650765828,0,0,2
37,Nucleotide Excision Repair WP4753,0.1171081713346053,inf,inf,"['CETN2', 'POLE3']",0.8096701650765828,0,0,2
38,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.1171081713346053,inf,inf,"['PTTG1', 'ANAPC11']",0.8096701650765828,0,0,2
39,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.1190691419230269,5.787272727272727,12.315611109649183,"['CD63', 'CD81', 'SOD1']",0.8096701650765828,0,0,3
40,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.1190691419230269,5.787272727272727,12.315611109649183,"['LDHA', 'PKM', 'PGK1']",0.8096701650765828,0,0,3
41,Calcium Regulation in the Cardiac Cell WP536,0.12282183947673586,1.9356617647058822,4.059122272313579,"['RGS4', 'GNG3', 'PRKAR1A', 'YWHAB', 'CALM3', 'CALR', 'CALM1', 'CALM2', 'YWHAH']",0.814818057016394,0,0,9
42,Androgen receptor signaling pathway WP138,0.13540558816517914,2.3188299817184643,4.636455674043586,"['PRDX1', 'BAG1', 'STUB1', 'CALR', 'FKBP4', 'RAN']",0.8565190693239239,0,0,6
43,EGF/EGFR signaling pathway WP437,0.13540558816517914,2.3188299817184643,4.636455674043586,"['NDUFA13', 'CFL1', 'STMN1', 'AP2S1', 'AP2M1', 'ARF6']",0.8565190693239239,0,0,6
44,Translation Factors WP107,0.18706185615143803,2.5719489981785064,4.31139909033604,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF1']",0.9601731040895096,0,0,4
45,Copper homeostasis WP3286,0.18706185615143803,2.5719489981785064,4.31139909033604,"['SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9601731040895096,0,0,4
46,G Protein Signaling Pathways WP35,0.18706185615143803,2.5719489981785064,4.31139909033604,"['GNG3', 'PRKAR1A', 'CALM1', 'CALM2']",0.9601731040895096,0,0,4
47,Leptin signaling pathway WP2034,0.18706185615143803,2.5719489981785064,4.31139909033604,"['SOCS3', 'CISH', 'BAD', 'CFL2']",0.9601731040895096,0,0,4
48,Non-small cell lung cancer WP4255,0.18706185615143803,2.5719489981785064,4.31139909033604,"['GADD45B', 'BAD', 'GADD45A', 'CYCS']",0.9601731040895096,0,0,4
49,Proteasome Degradation WP183,0.18706185615143803,2.5719489981785064,4.31139909033604,"['PSMD8', 'PSMB6', 'H2AFZ', 'PSMB10']",0.9601731040895096,0,0,4
50,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.18706185615143803,2.5719489981785064,4.31139909033604,"['CREB3', 'CALM3', 'CALM1', 'CALM2']",0.9601731040895096,0,0,4
51,Amyotrophic lateral sclerosis (ALS) WP2447,0.22321340048113664,2.890909090909091,4.335285362770969,"['BAD', 'NEFL', 'SOD1']",0.9601731040895096,0,0,3
52,Common Pathways Underlying Drug Addiction WP2636,0.22321340048113664,2.890909090909091,4.335285362770969,"['CALM1', 'CALM2', 'ACTG1']",0.9601731040895096,0,0,3
53,Ectoderm Differentiation WP2858,0.22321340048113664,2.890909090909091,4.335285362770969,"['ARHGDIG', 'JAKMIP1', 'LY6E']",0.9601731040895096,0,0,3
54,Fragile X Syndrome  WP4549,0.22321340048113664,2.890909090909091,4.335285362770969,"['PRKAR1A', 'AP2S1', 'AP2M1']",0.9601731040895096,0,0,3
55,Glycogen Synthesis and Degradation WP500,0.22321340048113664,2.890909090909091,4.335285362770969,"['CALM3', 'CALM1', 'CALM2']",0.9601731040895096,0,0,3
56,IL-6 signaling pathway WP364,0.22321340048113664,2.890909090909091,4.335285362770969,"['SOCS3', 'BAD', 'NR2F6']",0.9601731040895096,0,0,3
57,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.22321340048113664,2.890909090909091,4.335285362770969,"['CISH', 'CALM1', 'CALM2']",0.9601731040895096,0,0,3
58,Integrated breast cancer pathway WP1984,0.23149548945022558,1.9288321167883211,2.8222572963005486,"['GADD45A', 'BAD', 'PHB', 'FAU', 'JAKMIP1']",0.9601731040895096,0,0,5
59,Serotonin and anxiety WP3947,0.2713164885641559,3.851179673321234,5.0237455949937635,"['POMC', 'CRH']",0.9601731040895096,0,0,2
60,ACE Inhibitor Pathway WP554,0.2713164885641559,3.851179673321234,5.0237455949937635,"['MAS1', 'ATP6AP2']",0.9601731040895096,0,0,2
61,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.2713164885641559,3.851179673321234,5.0237455949937635,"['XBP1', 'DDIT3']",0.9601731040895096,0,0,2
62,Endothelin Pathways WP2197,0.2713164885641559,3.851179673321234,5.0237455949937635,"['CALM1', 'CALM2']",0.9601731040895096,0,0,2
63,GABA receptor Signaling WP4159,0.2713164885641559,3.851179673321234,5.0237455949937635,"['AP2S1', 'AP2M1']",0.9601731040895096,0,0,2
64,Joubert Syndrome WP4656,0.2713164885641559,3.851179673321234,5.0237455949937635,"['CETN2', 'ARL2']",0.9601731040895096,0,0,2
65,Melatonin metabolism and effects WP3298,0.2713164885641559,3.851179673321234,5.0237455949937635,"['CALM1', 'CALM2']",0.9601731040895096,0,0,2
66,Nanomaterial induced apoptosis WP2507,0.2713164885641559,3.851179673321234,5.0237455949937635,"['ENDOG', 'CYCS']",0.9601731040895096,0,0,2
67,Nucleotide metabolism WP404,0.2713164885641559,3.851179673321234,5.0237455949937635,"['NME2', 'OAZ1']",0.9601731040895096,0,0,2
68,One-carbon metabolism and related pathways WP3940,0.2713164885641559,3.851179673321234,5.0237455949937635,"['GPX4', 'SOD1']",0.9601731040895096,0,0,2
69,Parkinson's disease pathway WP2371,0.2713164885641559,3.851179673321234,5.0237455949937635,"['PINK1', 'CYCS']",0.9601731040895096,0,0,2
70,Small cell lung cancer WP4658,0.31157039532220454,1.6058394160583942,1.8726174830687967,"['LAMB3', 'GADD45B', 'GADD45A', 'CYCS', 'SKP1']",0.9601731040895096,0,0,5
71,IL-18 signaling pathway WP4754,0.33330983262821573,1.2278630460448643,1.3490320011801742,"['MTCH1', 'NRN1', 'IMP3', 'CD81', 'BAD', 'COX17', 'NDUFC1', 'SOCS3', 'ARL4D', 'TMSB4X', 'STMN1', 'CYCS', 'ITM2C', 'ARF6']",0.9601731040895096,0,0,14
72,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.3374918105589428,1.9254545454545455,2.091455749052705,"['POMC', 'CREB3', 'BAD']",0.9601731040895096,0,0,3
73,Notch Signaling Pathway Netpath WP61,0.3374918105589428,1.9254545454545455,2.091455749052705,"['PSENEN', 'SKP1', 'DLL3']",0.9601731040895096,0,0,3
74,Oxidative Damage WP3941,0.3374918105589428,1.9254545454545455,2.091455749052705,"['BAD', 'GADD45A', 'CYCS']",0.9601731040895096,0,0,3
75,Regulation of Microtubule Cytoskeleton WP2038,0.3374918105589428,1.9254545454545455,2.091455749052705,"['PARD6A', 'CFL2', 'STMN1']",0.9601731040895096,0,0,3
76,Statin inhibition of cholesterol production WP430,0.3424146731495678,inf,inf,['LPL'],0.9601731040895096,0,0,1
77,Autophagy WP4923,0.3424146731495678,inf,inf,['ATG101'],0.9601731040895096,0,0,1
78,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.3424146731495678,inf,inf,['MDH2'],0.9601731040895096,0,0,1
79,Triacylglyceride synthesis WP325,0.3424146731495678,inf,inf,['LPL'],0.9601731040895096,0,0,1
80,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3424146731495678,inf,inf,['CCK'],0.9601731040895096,0,0,1
81,"Cerebral organic acidurias, including diseases WP4519",0.3424146731495678,inf,inf,['MDH2'],0.9601731040895096,0,0,1
82,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.3424146731495678,inf,inf,['DHCR24'],0.9601731040895096,0,0,1
83,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.3424146731495678,inf,inf,['DHCR24'],0.9601731040895096,0,0,1
84,Urea cycle and associated pathways WP4595,0.3424146731495678,inf,inf,['MDH2'],0.9601731040895096,0,0,1
85,Composition of Lipid Particles WP3601,0.3424146731495678,inf,inf,['LPL'],0.9601731040895096,0,0,1
86,DNA Mismatch Repair WP531,0.3424146731495678,inf,inf,['POLE3'],0.9601731040895096,0,0,1
87,Gastric Cancer Network 2 WP2363,0.3424146731495678,inf,inf,['S100A6'],0.9601731040895096,0,0,1
88,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3424146731495678,inf,inf,['LDHA'],0.9601731040895096,0,0,1
89,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3424146731495678,inf,inf,['ELOB'],0.9601731040895096,0,0,1
90,Lipid Metabolism Pathway WP3965,0.3424146731495678,inf,inf,['PRKAR1A'],0.9601731040895096,0,0,1
91,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3424146731495678,inf,inf,['SOCS3'],0.9601731040895096,0,0,1
92,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3424146731495678,inf,inf,['LPL'],0.9601731040895096,0,0,1
93,miRNA Biogenesis WP2338,0.3424146731495678,inf,inf,['RAN'],0.9601731040895096,0,0,1
94,Mitochondrial CII Assembly WP4920,0.3424146731495678,inf,inf,['SDHAF1'],0.9601731040895096,0,0,1
95,MTHFR deficiency WP4288,0.3424146731495678,inf,inf,['CYCS'],0.9601731040895096,0,0,1
96,Osteoclast Signaling WP12,0.3424146731495678,inf,inf,['ATP6V1G1'],0.9601731040895096,0,0,1
97,SARS-CoV-2 mitochondrial interactions WP5038,0.3424146731495678,inf,inf,['PHB'],0.9601731040895096,0,0,1
98,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.37195484791167055,1.540255009107468,1.523285724955509,"['GADD45B', 'BAD', 'GADD45A', 'CYCS']",0.9711955015703807,0,0,4
99,DNA damage response WP707,0.37195484791167055,1.540255009107468,1.523285724955509,"['GADD45B', 'CDK5', 'GADD45A', 'CYCS']",0.9711955015703807,0,0,4
100,miRNA regulation of DNA damage response WP1530,0.37195484791167055,1.540255009107468,1.523285724955509,"['GADD45B', 'CDK5', 'GADD45A', 'CYCS']",0.9711955015703807,0,0,4
101,Ras signaling WP4223,0.4107847936911492,1.283363802559415,1.1417905743998469,"['GNG3', 'BAD', 'CALM3', 'CALM1', 'CALM2', 'ARF6']",0.9711955015703807,0,0,6
102,Cardiac Hypertrophic Response WP2795,0.42356374907467653,1.9237749546279492,1.6526212739445216,"['CALM1', 'CALM2']",0.9711955015703807,0,0,2
103,Unfolded protein response WP4925,0.42356374907467653,1.9237749546279492,1.6526212739445216,"['XBP1', 'DDIT3']",0.9711955015703807,0,0,2
104,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.42356374907467653,1.9237749546279492,1.6526212739445216,"['CFL1', 'BANF1']",0.9711955015703807,0,0,2
105,Intraflagellar transport proteins binding to dynein WP4532,0.42356374907467653,1.9237749546279492,1.6526212739445216,"['DYNLRB1', 'DYNLL1']",0.9711955015703807,0,0,2
106,Physiological and pathological hypertrophy of the heart WP1528,0.42356374907467653,1.9237749546279492,1.6526212739445216,"['CALM1', 'CALM2']",0.9711955015703807,0,0,2
107,PPAR signaling pathway WP3942,0.42356374907467653,1.9237749546279492,1.6526212739445216,"['FABP7', 'LPL']",0.9711955015703807,0,0,2
108,Retinoblastoma gene in cancer WP2446,0.42356374907467653,1.9237749546279492,1.6526212739445216,"['H2AFZ', 'STMN1']",0.9711955015703807,0,0,2
109,16p11.2 proximal deletion syndrome WP4949,0.45031422445180386,1.4427272727272726,1.1510217597457695,"['ALDOA', 'SEZ6L2', 'CCT7']",0.9711955015703807,0,0,3
110,Acute viral myocarditis WP4298,0.45031422445180386,1.4427272727272726,1.1510217597457695,"['ENDOG', 'CYCS', 'EIF4G2']",0.9711955015703807,0,0,3
111,Amino Acid metabolism WP3925,0.45031422445180386,1.4427272727272726,1.1510217597457695,"['LDHA', 'PKM', 'MDH2']",0.9711955015703807,0,0,3
112,CAMKK2  Pathway WP4874,0.45031422445180386,1.4427272727272726,1.1510217597457695,"['FIS1', 'CALM1', 'CALM2']",0.9711955015703807,0,0,3
113,Cytosolic DNA-sensing pathway WP4655,0.45031422445180386,1.4427272727272726,1.1510217597457695,"['POLR3K', 'POLR2K', 'POLR2L']",0.9711955015703807,0,0,3
114,G1 to S cell cycle control WP45,0.45031422445180386,1.4427272727272726,1.1510217597457695,"['CDKN2D', 'CREB3', 'GADD45A']",0.9711955015703807,0,0,3
115,Genotoxicity pathway WP4286,0.45031422445180386,1.4427272727272726,1.1510217597457695,"['RPS27', 'GADD45A', 'TRIAP1']",0.9711955015703807,0,0,3
116,Senescence and Autophagy in Cancer WP615,0.5536080290298095,1.0981004423627374,0.64930500328897,"['GABARAPL2', 'GABARAPL1', 'HMGA1', 'GABARAP']",0.9711955015703807,0,0,4
117,Complement system WP2806,0.5536080290298095,1.0981004423627374,0.64930500328897,"['FKBP2', 'RPS19', 'CD59', 'CALR']",0.9711955015703807,0,0,4
118,Exercise-induced Circadian Regulation WP410,0.5536080290298095,1.0981004423627374,0.64930500328897,"['DNAJA1', 'HSPA8', 'GSTP1', 'EIF4G2']",0.9711955015703807,0,0,4
119,Focal Adhesion WP306,0.5536080290298095,1.0981004423627374,0.64930500328897,"['LAMB3', 'BAD', 'MYL12B', 'ACTG1']",0.9711955015703807,0,0,4
120,Endometrial cancer WP4155,0.5542399376467687,1.1530909090909092,0.6805053468291483,"['GADD45B', 'BAD', 'GADD45A']",0.9711955015703807,0,0,3
121,Pancreatic adenocarcinoma pathway WP4263,0.5542399376467687,1.1530909090909092,0.6805053468291483,"['GADD45B', 'BAD', 'GADD45A']",0.9711955015703807,0,0,3
122,Prader-Willi and Angelman Syndrome WP3998,0.5542399376467687,1.1530909090909092,0.6805053468291483,"['POMC', 'PCSK1', 'NDN']",0.9711955015703807,0,0,3
123,Aryl Hydrocarbon Receptor Netpath WP2586,0.5571305492962748,1.281306715063521,0.7495076499860409,"['AIP', 'LPL']",0.9711955015703807,0,0,2
124,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.5571305492962748,1.281306715063521,0.7495076499860409,"['CALM1', 'CALM2']",0.9711955015703807,0,0,2
125,Thermogenesis WP4321,0.5571305492962748,1.281306715063521,0.7495076499860409,"['CREB3', 'ACTG1']",0.9711955015703807,0,0,2
126,Cardiac Progenitor Differentiation WP2406,0.5571305492962748,1.281306715063521,0.7495076499860409,"['MESP1', 'THY1']",0.9711955015703807,0,0,2
127,IL-2 signaling pathway WP49,0.5571305492962748,1.281306715063521,0.7495076499860409,"['SOCS3', 'CISH']",0.9711955015703807,0,0,2
128,IL-3 signaling pathway WP286,0.5571305492962748,1.281306715063521,0.7495076499860409,"['YWHAB', 'BAD']",0.9711955015703807,0,0,2
129,MET in type 1 papillary renal cell carcinoma WP4205,0.5571305492962748,1.281306715063521,0.7495076499860409,"['BAD', 'RPL11']",0.9711955015703807,0,0,2
130,Pre-implantation embryo WP3527,0.5571305492962748,1.281306715063521,0.7495076499860409,"['DDIT3', 'HMGA1']",0.9711955015703807,0,0,2
131,Regulatory circuits of the STAT3 signaling pathway WP4538,0.5571305492962748,1.281306715063521,0.7495076499860409,"['SOCS3', 'STMN1']",0.9711955015703807,0,0,2
132,Serotonin and anxiety-related events WP3944,0.5677208998150387,1.9221014492753623,1.0881503645282182,['CRH'],0.9711955015703807,0,0,1
133,Alpha 6 Beta 4 signaling pathway WP244,0.5677208998150387,1.9221014492753623,1.0881503645282182,['LAMB3'],0.9711955015703807,0,0,1
134,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5677208998150387,1.9221014492753623,1.0881503645282182,['DLL3'],0.9711955015703807,0,0,1
135,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.5677208998150387,1.9221014492753623,1.0881503645282182,['LPL'],0.9711955015703807,0,0,1
136,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5677208998150387,1.9221014492753623,1.0881503645282182,['LPL'],0.9711955015703807,0,0,1
137,Cannabinoid receptor signaling WP3869,0.5677208998150387,1.9221014492753623,1.0881503645282182,['PRKAR1A'],0.9711955015703807,0,0,1
138,TP53 network WP1742,0.5677208998150387,1.9221014492753623,1.0881503645282182,['GADD45A'],0.9711955015703807,0,0,1
139,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.5677208998150387,1.9221014492753623,1.0881503645282182,['EIF4A2'],0.9711955015703807,0,0,1
140,Type 2 papillary renal cell carcinoma WP4241,0.5677208998150387,1.9221014492753623,1.0881503645282182,['ELOB'],0.9711955015703807,0,0,1
141,Type II interferon signaling (IFNG) WP619,0.5677208998150387,1.9221014492753623,1.0881503645282182,['SOCS3'],0.9711955015703807,0,0,1
142,DNA Replication WP466,0.5677208998150387,1.9221014492753623,1.0881503645282182,['UBA52'],0.9711955015703807,0,0,1
143,Dopamine metabolism WP2436,0.5677208998150387,1.9221014492753623,1.0881503645282182,['SOD1'],0.9711955015703807,0,0,1
144,EPO Receptor Signaling WP581,0.5677208998150387,1.9221014492753623,1.0881503645282182,['CISH'],0.9711955015703807,0,0,1
145,Fatty acid transporters WP5061,0.5677208998150387,1.9221014492753623,1.0881503645282182,['FABP7'],0.9711955015703807,0,0,1
146,Genes related to primary cilium development (based on CRISPR) WP4536,0.5677208998150387,1.9221014492753623,1.0881503645282182,['DYNLL1'],0.9711955015703807,0,0,1
147,Glutathione metabolism WP100,0.5677208998150387,1.9221014492753623,1.0881503645282182,['GPX4'],0.9711955015703807,0,0,1
148,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5677208998150387,1.9221014492753623,1.0881503645282182,['BAD'],0.9711955015703807,0,0,1
149,Integrin-mediated Cell Adhesion WP185,0.5677208998150387,1.9221014492753623,1.0881503645282182,['CAPNS1'],0.9711955015703807,0,0,1
150,Interferon type I signaling pathways WP585,0.5677208998150387,1.9221014492753623,1.0881503645282182,['SOCS3'],0.9711955015703807,0,0,1
151,Iron metabolism in placenta WP2007,0.5677208998150387,1.9221014492753623,1.0881503645282182,['FTH1'],0.9711955015703807,0,0,1
152,Leptin Insulin Overlap WP3935,0.5677208998150387,1.9221014492753623,1.0881503645282182,['SOCS3'],0.9711955015703807,0,0,1
153,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.5677208998150387,1.9221014492753623,1.0881503645282182,['ATG101'],0.9711955015703807,0,0,1
154,Notch Signaling WP268,0.5677208998150387,1.9221014492753623,1.0881503645282182,['DLL3'],0.9711955015703807,0,0,1
155,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5677208998150387,1.9221014492753623,1.0881503645282182,['EIF1'],0.9711955015703807,0,0,1
156,Nuclear receptors WP170,0.5677208998150387,1.9221014492753623,1.0881503645282182,['NR2F6'],0.9711955015703807,0,0,1
157,Purine metabolism and related disorders WP4224,0.5677208998150387,1.9221014492753623,1.0881503645282182,['APRT'],0.9711955015703807,0,0,1
158,Purine metabolism WP4792,0.5677208998150387,1.9221014492753623,1.0881503645282182,['APRT'],0.9711955015703807,0,0,1
159,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.5677208998150387,1.9221014492753623,1.0881503645282182,['MAS1'],0.9711955015703807,0,0,1
160,Regulation of Actin Cytoskeleton WP51,0.6254819407513033,0.9598540145985401,0.4503950072030404,"['CFL2', 'TMSB4X', 'CFL1', 'BRK1', 'ACTG1']",0.9826251528488331,0,0,5
161,Apoptosis Modulation and Signaling WP1772,0.6332057741313453,0.9599271402550091,0.4386481447888447,"['ENDOG', 'CAPNS1', 'BAD', 'CYCS']",0.9826251528488331,0,0,4
162,22q11.2 copy number variation syndrome WP4657,0.645382405506984,0.96,0.4203957706688053,"['CYP26B1', 'MRPL40', 'RAN']",0.9826251528488331,0,0,3
163,Insulin Signaling WP481,0.645382405506984,0.96,0.4203957706688053,"['SOCS3', 'XBP1', 'ARF6']",0.9826251528488331,0,0,3
164,Apoptosis WP254,0.6669498126786332,0.9600725952813067,0.38886826411502706,"['BAD', 'CYCS']",0.9826251528488331,0,0,2
165,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6669498126786332,0.9600725952813067,0.38886826411502706,"['CALM1', 'CALM2']",0.9826251528488331,0,0,2
166,Endochondral Ossification WP474,0.6669498126786332,0.9600725952813067,0.38886826411502706,"['CALM1', 'CALM2']",0.9826251528488331,0,0,2
167,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6669498126786332,0.9600725952813067,0.38886826411502706,"['CYCS', 'ACTG1']",0.9826251528488331,0,0,2
168,Ferroptosis WP4313,0.6669498126786332,0.9600725952813067,0.38886826411502706,"['GPX4', 'FTH1']",0.9826251528488331,0,0,2
169,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6669498126786332,0.9600725952813067,0.38886826411502706,"['RAB3A', 'NEFL']",0.9826251528488331,0,0,2
170,Modulators of TCR signaling and T cell activation WP5072,0.6669498126786332,0.9600725952813067,0.38886826411502706,"['NDUFB10', 'ELOB']",0.9826251528488331,0,0,2
171,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7029882687136816,0.8524590163934426,0.30041940800361094,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9826251528488331,0,0,4
172,Apoptosis Modulation by HSP70 WP384,0.715922905160151,0.9601449275362319,0.32086391277779847,['CYCS'],0.9826251528488331,0,0,1
173,Striated Muscle Contraction Pathway WP383,0.715922905160151,0.9601449275362319,0.32086391277779847,['ACTG1'],0.9826251528488331,0,0,1
174,Sulfation Biotransformation Reaction WP692,0.715922905160151,0.9601449275362319,0.32086391277779847,['SULT4A1'],0.9826251528488331,0,0,1
175,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.715922905160151,0.9601449275362319,0.32086391277779847,['ACTG1'],0.9826251528488331,0,0,1
176,Blood Clotting Cascade WP272,0.715922905160151,0.9601449275362319,0.32086391277779847,['F8A1'],0.9826251528488331,0,0,1
177,Canonical and non-canonical Notch signaling WP3845,0.715922905160151,0.9601449275362319,0.32086391277779847,['DLL3'],0.9826251528488331,0,0,1
178,Transcriptional cascade regulating adipogenesis WP4211,0.715922905160151,0.9601449275362319,0.32086391277779847,['DDIT3'],0.9826251528488331,0,0,1
179,Vitamin D-sensitive calcium signaling in depression WP4698,0.715922905160151,0.9601449275362319,0.32086391277779847,['GPX4'],0.9826251528488331,0,0,1
180,White fat cell differentiation WP4149,0.715922905160151,0.9601449275362319,0.32086391277779847,['DDIT3'],0.9826251528488331,0,0,1
181,DNA IR-damage and cellular response via ATR WP4016,0.715922905160151,0.9601449275362319,0.32086391277779847,['FEN1'],0.9826251528488331,0,0,1
182,DNA IR-double strand breaks and cellular response via ATM WP3959,0.715922905160151,0.9601449275362319,0.32086391277779847,['CDK5'],0.9826251528488331,0,0,1
183,Dual hijack model of Vif in HIV infection WP3300,0.715922905160151,0.9601449275362319,0.32086391277779847,['ELOB'],0.9826251528488331,0,0,1
184,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.715922905160151,0.9601449275362319,0.32086391277779847,['BAD'],0.9826251528488331,0,0,1
185,Gastric acid production WP2596,0.715922905160151,0.9601449275362319,0.32086391277779847,['CCK'],0.9826251528488331,0,0,1
186,Genes targeted by miRNAs in adipocytes WP1992,0.715922905160151,0.9601449275362319,0.32086391277779847,['TMSB4X'],0.9826251528488331,0,0,1
187,Hippo-Merlin Signaling Dysregulation WP4541,0.715922905160151,0.9601449275362319,0.32086391277779847,['PRKAR1A'],0.9826251528488331,0,0,1
188,Histone Modifications WP2369,0.715922905160151,0.9601449275362319,0.32086391277779847,['SET'],0.9826251528488331,0,0,1
189,Interleukin-11 Signaling Pathway WP2332,0.715922905160151,0.9601449275362319,0.32086391277779847,['SOCS3'],0.9826251528488331,0,0,1
190,Kit receptor signaling pathway WP304,0.715922905160151,0.9601449275362319,0.32086391277779847,['BAD'],0.9826251528488331,0,0,1
191,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.715922905160151,0.9601449275362319,0.32086391277779847,['ACTG1'],0.9826251528488331,0,0,1
192,Nephrotic syndrome WP4758,0.715922905160151,0.9601449275362319,0.32086391277779847,['ARHGDIA'],0.9826251528488331,0,0,1
193,Nicotine Activity on Dopaminergic Neurons WP1602,0.715922905160151,0.9601449275362319,0.32086391277779847,['CDK5'],0.9826251528488331,0,0,1
194,NOTCH1 regulation of endothelial cell calcification WP3413,0.715922905160151,0.9601449275362319,0.32086391277779847,['DLL3'],0.9826251528488331,0,0,1
195,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.715922905160151,0.9601449275362319,0.32086391277779847,['LPL'],0.9826251528488331,0,0,1
196,p38 MAPK Signaling Pathway WP400,0.715922905160151,0.9601449275362319,0.32086391277779847,['DDIT3'],0.9826251528488331,0,0,1
197,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.715922905160151,0.9601449275362319,0.32086391277779847,['BAD'],0.9826251528488331,0,0,1
198,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.715922905160151,0.9601449275362319,0.32086391277779847,['LDHA'],0.9826251528488331,0,0,1
199,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.733183323652672,0.8211021154348394,0.25483684846908333,"['PRKAR1A', 'YWHAB', 'ALDOA', 'GAPDH', 'SLC25A4', 'YWHAH']",0.9826251528488331,0,0,6
200,3q29 copy number variation syndrome WP4906,0.7536039375307092,0.7673321234119782,0.21706930354013373,"['DYNLRB1', 'DYNLL1']",0.9826251528488331,0,0,2
201,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7536039375307092,0.7673321234119782,0.21706930354013373,"['BEX3', 'SOCS3']",0.9826251528488331,0,0,2
202,Vitamin A and carotenoid metabolism WP716,0.7536039375307092,0.7673321234119782,0.21706930354013373,"['CYP26B1', 'LPL']",0.9826251528488331,0,0,2
203,Ebola Virus Pathway on Host WP4217,0.7536039375307092,0.7673321234119782,0.21706930354013373,"['SOCS3', 'ACTG1']",0.9826251528488331,0,0,2
204,Folate Metabolism WP176,0.7536039375307092,0.7673321234119782,0.21706930354013373,"['GPX4', 'SOD1']",0.9826251528488331,0,0,2
205,IL-4 signaling pathway WP395,0.7536039375307092,0.7673321234119782,0.21706930354013373,"['SOCS3', 'BAD']",0.9826251528488331,0,0,2
206,Mesodermal commitment pathway WP2857,0.7536039375307092,0.7673321234119782,0.21706930354013373,"['PRKAR1A', 'RPL38']",0.9826251528488331,0,0,2
207,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7536039375307092,0.7673321234119782,0.21706930354013373,"['BAD', 'STMN1']",0.9826251528488331,0,0,2
208,Circadian rhythm related genes WP3594,0.7682297344465934,0.7880844645550528,0.2077914387214734,"['CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1', 'NR2F6', 'HCRTR1']",0.9826251528488331,0,0,7
209,TGF-beta Signaling Pathway WP366,0.7857441098485933,0.7186363636363636,0.17328054608437904,"['PARD6A', 'CITED1', 'SKP1']",0.9826251528488331,0,0,3
210,Hepatitis B infection WP4666,0.8124842183428809,0.6961417453220732,0.14455995148909828,"['CREB3', 'YWHAB', 'BAD', 'CYCS']",0.9826251528488331,0,0,4
211,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8124842183428809,0.6961417453220732,0.14455995148909828,"['PSMD8', 'HSPA8', 'TUBA1A', 'STUB1']",0.9826251528488331,0,0,4
212,16p11.2 distal deletion syndrome WP4950,0.8133757836501726,0.6394927536231884,0.13209493908063843,['CD81'],0.9826251528488331,0,0,1
213,ATM Signaling Network in Development and Disease  WP3878,0.8133757836501726,0.6394927536231884,0.13209493908063843,['CDK5'],0.9826251528488331,0,0,1
214,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8133757836501726,0.6394927536231884,0.13209493908063843,['CISH'],0.9826251528488331,0,0,1
215,Vitamin B12 metabolism WP1533,0.8133757836501726,0.6394927536231884,0.13209493908063843,['SOD1'],0.9826251528488331,0,0,1
216,Galanin receptor pathway WP4970,0.8133757836501726,0.6394927536231884,0.13209493908063843,['POMC'],0.9826251528488331,0,0,1
217,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8133757836501726,0.6394927536231884,0.13209493908063843,['DDIT3'],0.9826251528488331,0,0,1
218,IL-7 signaling pathway WP205,0.8133757836501726,0.6394927536231884,0.13209493908063843,['BAD'],0.9826251528488331,0,0,1
219,Imatinib and Chronic Myeloid Leukemia WP3640,0.8133757836501726,0.6394927536231884,0.13209493908063843,['GADD45A'],0.9826251528488331,0,0,1
220,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8133757836501726,0.6394927536231884,0.13209493908063843,['SUPT4H1'],0.9826251528488331,0,0,1
221,Integrated Cancer Pathway WP1971,0.8133757836501726,0.6394927536231884,0.13209493908063843,['BAD'],0.9826251528488331,0,0,1
222,Oxidation by Cytochrome P450 WP43,0.8133757836501726,0.6394927536231884,0.13209493908063843,['CYP26B1'],0.9826251528488331,0,0,1
223,Oxidative Stress WP408,0.8133757836501726,0.6394927536231884,0.13209493908063843,['SOD1'],0.9826251528488331,0,0,1
224,Prostaglandin Synthesis and Regulation WP98,0.8133757836501726,0.6394927536231884,0.13209493908063843,['S100A6'],0.9826251528488331,0,0,1
225,Sleep regulation WP3591,0.8200584915319306,0.6388384754990926,0.1267325277063726,"['CRH', 'HCRTR1']",0.9826251528488331,0,0,2
226,AGE/RAGE pathway WP2324,0.8200584915319306,0.6388384754990926,0.1267325277063726,"['CYCS', 'SOD1']",0.9826251528488331,0,0,2
227,Male infertility WP4673,0.8200584915319306,0.6388384754990926,0.1267325277063726,"['CYP26B1', 'HMGA1']",0.9826251528488331,0,0,2
228,Proximal tubule transport WP4917,0.8365901316579385,0.6381818181818182,0.11386504827444725,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1F']",0.9944285213010582,0,0,3
229,Metapathway biotransformation Phase I and II WP702,0.8534298587645718,0.6375227686703097,0.1010422081819729,"['CYP26B1', 'GPX4', 'GSTP1', 'SULT4A1']",0.9944285213010582,0,0,4
230,Breast cancer pathway WP4262,0.8689445857332586,0.6368613138686131,0.08946368127453498,"['FRAT2', 'GADD45B', 'GADD45A', 'SKP1', 'DLL3']",0.9944285213010582,0,0,5
231,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.869965831930518,0.54705729841846,0.0762058156826291,"['CALM1', 'CALM2']",0.9944285213010582,0,0,2
232,Endoderm differentiation WP2853,0.869965831930518,0.54705729841846,0.0762058156826291,"['TCEAL2', 'NME1']",0.9944285213010582,0,0,2
233,Aryl Hydrocarbon Receptor Pathway WP2873,0.8774369305597572,0.4791666666666667,0.06265113761075984,['AIP'],0.9944285213010582,0,0,1
234,B Cell Receptor Signaling Pathway WP23,0.8774369305597572,0.4791666666666667,0.06265113761075984,['CD81'],0.9944285213010582,0,0,1
235,Ciliopathies WP4803,0.8774369305597572,0.4791666666666667,0.06265113761075984,['NEK2'],0.9944285213010582,0,0,1
236,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.8774369305597572,0.4791666666666667,0.06265113761075984,['H2AFZ'],0.9944285213010582,0,0,1
237,miRNA regulation of prostate cancer signaling pathways WP3981,0.8774369305597572,0.4791666666666667,0.06265113761075984,['BAD'],0.9944285213010582,0,0,1
238,Neural Crest Differentiation WP2064,0.8774369305597572,0.4791666666666667,0.06265113761075984,['DLL3'],0.9944285213010582,0,0,1
239,Pathways Regulating Hippo Signaling WP4540,0.8774369305597572,0.4791666666666667,0.06265113761075984,['PRKAR1A'],0.9944285213010582,0,0,1
240,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8774369305597572,0.4791666666666667,0.06265113761075984,['GSTP1'],0.9944285213010582,0,0,1
241,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8865219987096404,0.5879220961188174,0.07081482758848433,"['RAB3A', 'CDK5', 'BAD', 'CFL1']",0.9986078283041802,0,0,4
242,Corticotropin-releasing hormone signaling pathway WP2355,0.9068485956628036,0.4782214156079855,0.046760380748424035,"['POMC', 'CRH']",0.9986078283041802,0,0,2
243,Pathogenic Escherichia coli infection WP2272,0.9068485956628036,0.4782214156079855,0.046760380748424035,"['TUBA1A', 'ACTG1']",0.9986078283041802,0,0,2
244,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9193684950403933,0.5608630313439245,0.04715078086324063,"['CREB3', 'GNG3', 'LAMB3', 'BAD', 'PELO']",0.9986078283041802,0,0,5
245,ATM Signaling Pathway WP2516,0.9195342013935498,0.3829710144927536,0.03212668777751796,['GADD45A'],0.9986078283041802,0,0,1
246,Tryptophan metabolism WP465,0.9195342013935498,0.3829710144927536,0.03212668777751796,['DHCR24'],0.9986078283041802,0,0,1
247,NRF2 pathway WP2884,0.9315989049789946,0.4772727272727273,0.03381616464180618,"['FTH1', 'PRDX1', 'GSTP1']",0.9986078283041802,0,0,3
248,TNF-alpha signaling pathway WP231,0.9337605963846998,0.4246823956442831,0.02910569054218487,"['BAD', 'SKP1']",0.9986078283041802,0,0,2
249,Prolactin Signaling Pathway WP2037,0.9337605963846998,0.4246823956442831,0.02910569054218487,"['SOCS3', 'CISH']",0.9986078283041802,0,0,2
250,Chemokine signaling pathway WP3929,0.9471891018781663,0.3188405797101449,0.017299180461096672,['GNG3'],0.9986078283041802,0,0,1
251,DNA damage response (only ATM dependent) WP710,0.9471891018781663,0.3188405797101449,0.017299180461096672,['BAD'],0.9986078283041802,0,0,1
252,ErbB signaling pathway WP673,0.9471891018781663,0.3188405797101449,0.017299180461096672,['BAD'],0.9986078283041802,0,0,1
253,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9471891018781663,0.3188405797101449,0.017299180461096672,['IFI27L2'],0.9986078283041802,0,0,1
254,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9471891018781663,0.3188405797101449,0.017299180461096672,['NDUFA13'],0.9986078283041802,0,0,1
255,p53 transcriptional gene network WP4963,0.9471891018781663,0.3188405797101449,0.017299180461096672,['GADD45A'],0.9986078283041802,0,0,1
256,Peptide GPCRs WP24,0.9471891018781663,0.3188405797101449,0.017299180461096672,['HCRTR1'],0.9986078283041802,0,0,1
257,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9653504841841142,0.27303312629399584,0.009628253144849573,['MYL12B'],0.9986078283041802,0,0,1
258,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9653504841841142,0.27303312629399584,0.009628253144849573,['DLL3'],0.9986078283041802,0,0,1
259,Oncostatin M Signaling Pathway WP2374,0.9772734424341911,0.23867753623188406,0.005486906906512704,['SOCS3'],0.9986078283041802,0,0,1
260,Osteoblast differentiation WP4787,0.9772734424341911,0.23867753623188406,0.005486906906512704,['DLL3'],0.9986078283041802,0,0,1
261,PI3K-Akt signaling pathway WP4172,0.9845933034721319,0.37959927140255006,0.005893890962619505,"['CREB3', 'GNG3', 'LAMB3', 'BAD']",0.9986078283041802,0,0,4
262,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9850983120494745,0.21195652173913043,0.0031822799485403657,['FRAT2'],0.9986078283041802,0,0,1
263,Regulation of toll-like receptor signaling pathway WP1449,0.9850983120494745,0.21195652173913043,0.0031822799485403657,['CISH'],0.9986078283041802,0,0,1
264,MAPK Signaling Pathway WP382,0.9886796225602504,0.36117616445485295,0.0041119691885666484,"['HSPA8', 'GADD45A', 'DDIT3', 'STMN1']",0.9986078283041802,0,0,4
265,Spinal Cord Injury WP2431,0.9888866989878776,0.2717137671765621,0.003036541309920746,"['GADD45A', 'MIF']",0.9986078283041802,0,0,2
266,Wnt signaling WP428,0.9902319796027468,0.19057971014492753,0.001870738147877135,['FRAT2'],0.9986078283041802,0,0,1
267,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9902319796027468,0.19057971014492753,0.001870738147877135,['FRAT2'],0.9986078283041802,0,0,1
268,Nuclear Receptors Meta-Pathway WP2882,0.9933859075232422,0.3635597978663672,0.0024126055464226692,"['GADD45B', 'FTH1', 'PRDX1', 'GSTP1', 'AIP']",0.9986078283041802,0,0,5
269,Gastrin signaling pathway WP4659,0.9935989196599895,0.17308959156785245,0.0011115216588356777,['BAD'],0.9986078283041802,0,0,1
270,Glucocorticoid Receptor Pathway WP2880,0.9935989196599895,0.17308959156785245,0.0011115216588356777,['GADD45B'],0.9986078283041802,0,0,1
271,Vitamin D Receptor Pathway WP2877,0.9949364759942384,0.2841818181818182,0.0014426169111781775,"['CDKN2D', 'GADD45A', 'S100A6']",0.9986078283041802,0,0,3
272,"GPCRs, Class A Rhodopsin-like WP455",0.9999211783966894,0.13914095583787053,1.0967745478634867e-05,"['MAS1', 'HCRTR1']",0.9999211783966894,0,0,2
